The global nephrostomy devices market is likely to exceed revenue of $1.5 billion by 2026, according to a study produced by Acumen Research and Consulting, The industry also reflects the CAGR of 7.6% during 2019-2026. The report provides analysis of global Nephrostomy Devices market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
A greater awareness of the nephrostomy machines among doctors is driving the market, along with increasing instances of kidney stone illness. Another main factor in fuelling market growth is an increase in the incidence of ovarian, brown and prostate cancer and an improving healthcare infrastructure in developing countries.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1506
The largest market share in North America is anticipated due to the increased incidence of kidney stone and ovarian, liver and prostate cancers. For example, in 2018, about 22,240 new cases of ovarian cancer were diagnosed in the USA, according to the American Cancer Society. In this industry, major businesses emphasize product launches and innovations in current products. Cook Medical, for example, launched the Universa and the two urinary drainage sets in February 2017.
The increasing popularity of percutaneous nephrostomy processes (PCN) is a main factor in the development of the worldwide nephrostomy device industry. Traditional open-label operations require a number of complications, leading to enhanced demand for minimally invasive operations such as PCN. PCN is a minimally invasive procedure for the treatment of obstruction in the upper urinary tract. This procedure is used for patients with kidney stones of more than 2 cm in size as first-line treatment. The incision is around 1 cm lower and leads to quicker regeneration and shorter hospitalizations.
Over the years, ovarian, kidney stone, bladder and prostate cancer have considerably improved incidence. As a consequence, in a number of nations, governments and private organisations, underline the benefits of nephrostomy systems, while minimizing the composition of therapy costs. Similarly different sellers focus on projects that raise awareness of nephrostomy instruments. The development of the nephrostomy device industry is anticipated to propel such projects during the predicted era.
The increased incidence of kidney stone is the main driving factor in the worldwide market growth for nephrostomy products. In addition, the increased incidence of ovarian, bladder, prostate cancer, and other diseases are some of the prominent drivers of development in the market for nephrostomy instruments in patients who have been transplanted to kidney. Alternative processes such as ureteral stenting and percutaneous nephrostomy difficulties, however, are factors which hinder worldwide market development of nephrostomy instruments.
The segment guidewires resulted the world market in the nephrostomy industry in 2018 and is planned to grow further from 2019 to 2026 at the lowest CAGR.
The segment development is caused by increased instances of diseases of the kidney and urine and by less invasive guide wires.
2018 was dominated by the hospital segment. Percutaneous nephrostomy in most hospitals is conducted in comparison with emergency clinics, driving development in the segment.
The ASC segment is expected to record the largest CAGR because ASC’s nephrostomy systems, such as important cost conservation and customized services, have been commonly used by ASC.
North America is the market leader because of a large number of targets, the accessibility of expert surgeons, a well-established health industry and the rapid use of sophisticated healthcare instruments.
Key Players & Strategies
Cardinal Health; Teleflex, Inc.; Becton, Argon Medical; Boston Scientific Corp.; Dickinson and Company; Cook Medical; Coloplast Group; B. Braun Melsungen AG; Olympus Corp.; and Uresil LLC are major firms in the market, with a greater focus on the new product development, technological progress and M&A, to enhance their position on the worldwide market. Cook Medical, for example, started Universa together with two percutaneous urinary drainage sets in February 2017. The brand involves foley and ureteral catheters in various configurations and sizes to satisfy doctors and patients ‘ particular reference and needs.
Market Segment Analysis:
Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.
Market, By Product
- Nephrostomy Catheters
- Sheath Dilators
- Drainage Tubes
Market, By End Use
- Emergency Clinics
- Ambulatory Surgical Centers
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this Premium Research Report – https://www.acumenresearchandconsulting.com/buy-now/0/1506
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.